Harmony Biosciences Holdings, Inc.

NasdaqGM:HRMY Stock Report

Market Cap: US$1.8b

Harmony Biosciences Holdings Balance Sheet Health

Financial Health criteria checks 5/6

Harmony Biosciences Holdings has a total shareholder equity of $467.0M and total debt of $193.6M, which brings its debt-to-equity ratio to 41.4%. Its total assets and total liabilities are $811.4M and $344.5M respectively. Harmony Biosciences Holdings's EBIT is $192.0M making its interest coverage ratio 21.3. It has cash and short-term investments of $353.5M.

Key information

41.4%

Debt to equity ratio

US$193.57m

Debt

Interest coverage ratio21.3x
CashUS$353.46m
EquityUS$466.99m
Total liabilitiesUS$344.46m
Total assetsUS$811.45m

Recent financial health updates

Recent updates

These 4 Measures Indicate That Harmony Biosciences Holdings (NASDAQ:HRMY) Is Using Debt Safely

Apr 04
These 4 Measures Indicate That Harmony Biosciences Holdings (NASDAQ:HRMY) Is Using Debt Safely

Market Cool On Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Earnings

Feb 09
Market Cool On Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Earnings

Fewer Investors Than Expected Jumping On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Mar 21
Fewer Investors Than Expected Jumping On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Does Harmony Biosciences Holdings (NASDAQ:HRMY) Deserve A Spot On Your Watchlist?

Dec 01
Does Harmony Biosciences Holdings (NASDAQ:HRMY) Deserve A Spot On Your Watchlist?

Harmony Biosciences: In Harmony

Sep 23

We Ran A Stock Scan For Earnings Growth And Harmony Biosciences Holdings (NASDAQ:HRMY) Passed With Ease

Aug 05
We Ran A Stock Scan For Earnings Growth And Harmony Biosciences Holdings (NASDAQ:HRMY) Passed With Ease

Harmony Biosciences Non-GAAP EPS of $0.57 misses by $0.06, revenue of $107M beats by $6.25M

Aug 02

Harmony Biosciences: Steady Revenue Generator Looking For A Future

May 26

Harmony Biosciences: Strong Growth At A Reasonable Price

Mar 04

Our First Look At Harmony Biosciences

Nov 04

Harmony Biosciences Holdings' (NASDAQ:HRMY) Promising Earnings May Rest On Soft Foundations

Aug 17
Harmony Biosciences Holdings' (NASDAQ:HRMY) Promising Earnings May Rest On Soft Foundations

Harmony Biosciences Is Likely To Trade Higher As Wakix Sales Build

Jul 13

Harmony Bio reports clinical impact of Wakix in excessive daytime sleepiness at SLEEP 2021

Jun 10

Harmony Biosciences Holdings, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 14
Harmony Biosciences Holdings, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Financial Position Analysis

Short Term Liabilities: HRMY's short term assets ($451.1M) exceed its short term liabilities ($163.8M).

Long Term Liabilities: HRMY's short term assets ($451.1M) exceed its long term liabilities ($180.7M).


Debt to Equity History and Analysis

Debt Level: HRMY has more cash than its total debt.

Reducing Debt: HRMY's debt to equity ratio has increased from 0% to 41.4% over the past 5 years.

Debt Coverage: HRMY's debt is well covered by operating cash flow (113.3%).

Interest Coverage: HRMY's interest payments on its debt are well covered by EBIT (21.3x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.